BR0302074A - Revestimento antibiótico de corpos porosos e processos para produção, bem como uso da mesma - Google Patents

Revestimento antibiótico de corpos porosos e processos para produção, bem como uso da mesma

Info

Publication number
BR0302074A
BR0302074A BR0302074-6A BR0302074A BR0302074A BR 0302074 A BR0302074 A BR 0302074A BR 0302074 A BR0302074 A BR 0302074A BR 0302074 A BR0302074 A BR 0302074A
Authority
BR
Brazil
Prior art keywords
laurate
myristate
porous bodies
antibiotic
netylmycin
Prior art date
Application number
BR0302074-6A
Other languages
English (en)
Inventor
Sebastian Vogt
Matthias Schnabelrauch
Klaus-Dieter Kuehn
Original Assignee
Heraeus Kulzer Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh & Co Kg filed Critical Heraeus Kulzer Gmbh & Co Kg
Publication of BR0302074A publication Critical patent/BR0302074A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Abstract

"REVESTIMENTO ANTIBIóTICO DE CORPOS POROSOS E PROCESSOS PARA PRODUçãO, BEM COMO USO DA MESMA". A invenção refere-se à descrição de um revestimento antibiótico de corpos porosos e uso do mesmo. No sistema de poros de corpos porosos não-metálicos e de corpos porosos metálicos, é inserido um revestimento de pelo menos um sal de antibiótico, pouco solúvel em água ou no meio aquoso, do grupo do laurato de netilmicina, do miristato de netilmicina, do dodecilsulfato de netilmicina, do laurato de sisomicina, do miristato de sisomicina, do dodecilsulfato de sisomicina, do laurato de gentamicina, do miristato de gentamicina, do laurato de clindamicina, do laurato da amicacina, do miristato de amicacina, do dodecilsulfato de amicacina, do laurato de canamicina, do miristato de canamicina, do dodecilsulfato de canamicina, do laurato de tobramicina, do miristato de tobramicina, do dodecilsulfato de tobramicina, do miristato de ciprofloxacina, do dodecilsulfato de vancomicina, do laurato de vancomicina, do miristato de vancomicina, da teicoplanina de vancomicina e da teicoplanina de clindamicina. Os corpos porosos revestidos antibioticamente são usados como implantes.
BR0302074-6A 2002-06-21 2003-06-17 Revestimento antibiótico de corpos porosos e processos para produção, bem como uso da mesma BR0302074A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10227935A DE10227935B4 (de) 2002-06-21 2002-06-21 Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung

Publications (1)

Publication Number Publication Date
BR0302074A true BR0302074A (pt) 2004-04-27

Family

ID=29716605

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0302074-6A BRPI0302074B1 (pt) 2002-06-21 2003-06-17 Corpos porosos compreendendo um revestimento antibiótico, seus processos para produção, bem como seus usos
BR0302074-6A BR0302074A (pt) 2002-06-21 2003-06-17 Revestimento antibiótico de corpos porosos e processos para produção, bem como uso da mesma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0302074-6A BRPI0302074B1 (pt) 2002-06-21 2003-06-17 Corpos porosos compreendendo um revestimento antibiótico, seus processos para produção, bem como seus usos

Country Status (12)

Country Link
US (1) US7030093B2 (pt)
EP (1) EP1374923B1 (pt)
JP (1) JP4838488B2 (pt)
CN (1) CN1310682C (pt)
AT (1) ATE337802T1 (pt)
BR (2) BRPI0302074B1 (pt)
CA (1) CA2431984C (pt)
DE (3) DE10262176B4 (pt)
DK (1) DK1374923T3 (pt)
ES (1) ES2268220T3 (pt)
PT (1) PT1374923E (pt)
ZA (1) ZA200304798B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10318991A1 (de) * 2003-04-25 2004-11-18 Heraeus Kulzer Gmbh & Co. Kg Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung
DE102004021739B4 (de) * 2004-04-30 2007-11-22 Heraeus Kulzer Gmbh Metallimplantat mit Oberflächenbeschichtung
DE102004060666B3 (de) * 2004-12-15 2006-03-30 Heraeus Kulzer Gmbh Antibiotikum/Antibiotika enthaltendes Knochenersatzmaterial mit retardierender Wirkstofffreisetzung
CN101247789B (zh) 2005-05-27 2012-06-27 罗耶化学医药公司 可生物再吸收聚合物基质及其制造和使用方法
DE102006007245A1 (de) * 2006-02-15 2007-08-23 Heraeus Kulzer Gmbh Implantatmaterial
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
DE102006016598A1 (de) * 2006-04-06 2007-11-15 Heraeus Kulzer Gmbh Beschichtete Vaskulärimplantate
CN100418978C (zh) * 2006-11-01 2008-09-17 福州大学 一种采用膜分离技术制备西索米星的方法
DE102006060934A1 (de) * 2006-12-20 2008-06-26 Wolter, Dietmar F., Prof. Dr. Saugdrainage mit einem antibakteriell wirkenden Materialdepot
JP5131632B2 (ja) * 2007-05-10 2013-01-30 国立大学法人 新潟大学 薬物徐放材料及びその製造方法
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
AU2008349523B2 (en) * 2008-01-29 2013-10-24 Zimmer, Inc. Implant device for use in an implant system
US20090246250A1 (en) * 2008-03-27 2009-10-01 Affinergy Coating compositions having improved performance
DE102010020940B4 (de) 2010-05-19 2014-09-25 Heraeus Medical Gmbh Antibiotische Beschichtung
DE102010055560B4 (de) 2010-12-23 2017-02-23 Heraeus Medical Gmbh Beschichtungsvorrichtung
DE102010055559B4 (de) 2010-12-23 2015-10-29 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung
DE102010055562B4 (de) 2010-12-23 2015-07-09 Heraeus Medical Gmbh Beschichtungsvorrichtung und Beschichtungsverfahren
DE102010055561B4 (de) 2010-12-23 2015-12-31 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung
DE102011117526B4 (de) 2011-11-03 2015-07-30 Heraeus Medical Gmbh Beschichtungsverfahren und Beschichtungsvorrichtung für medizinische Implantate
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
BR112020000196A2 (pt) 2017-07-07 2020-07-07 Epicentrx, Inc. composições para administração parenteral de agentes terapêuticos

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091572A (en) * 1962-07-16 1963-05-28 Schering Corp Gentamycin and method of production
CA950831A (en) 1972-04-25 1974-07-09 Leonard D. Kurtz Biocidal salts
FR2272680B1 (pt) 1974-05-29 1978-07-21 Hosbon Sa Lab
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
DE3248328A1 (de) * 1982-12-28 1984-06-28 Bayer Ag, 5090 Leverkusen Schwerloesliche salze von aminoglykosiden sowie diese enthaltende formulierungen mit verzoegerter wirkstoff-freigabe
DE3377064D1 (en) 1982-12-28 1988-07-21 Bayer Ag Stable aminoglycoside-penicillin injection formulation
DE3414924A1 (de) * 1984-04-19 1985-10-31 Klaus Dr.med. Dr.med.habil. 8000 München Draenert Beschichtetes verankerungsteil fuer implantate
US4749585A (en) * 1986-04-11 1988-06-07 University Of Medicine And Dentistry Of New Jersey Antibiotic bonded prosthesis and process for producing same
DE3613213A1 (de) * 1986-04-18 1987-10-22 Merck Patent Gmbh Tricalciumphosphat fuer implantationsmaterialien
DE4304716A1 (de) * 1993-02-16 1994-08-18 Melzer Wolfgang Lokal applizierbares Arzneimittel mit verzögerter Freisetzung
DE4314871A1 (de) * 1993-05-05 1994-11-10 Merck Patent Gmbh Lösungsmittel für ein schwerlösliches Gentamicin-Salz
JPH0767895A (ja) * 1993-06-25 1995-03-14 Sumitomo Electric Ind Ltd 抗菌性人工血管及び抗菌性手術用縫合糸
DE4404018A1 (de) * 1994-02-09 1995-08-10 Merck Patent Gmbh Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
EP0985413A1 (de) * 1998-08-06 2000-03-15 Jörg Michael Dr. Dr. Schierholz Medizinprodukte mit retardierter pharmakologischer Aktivität und Verfahren zu ihrer Herstellung
DE19855421C2 (de) * 1998-11-02 2001-09-20 Alcove Surfaces Gmbh Implantat
DE10114245A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
IS6390A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra

Also Published As

Publication number Publication date
DE10227935B4 (de) 2007-10-04
EP1374923A2 (de) 2004-01-02
DK1374923T3 (da) 2006-12-27
PT1374923E (pt) 2006-11-30
EP1374923A3 (de) 2004-02-11
CA2431984A1 (en) 2003-12-21
CA2431984C (en) 2009-09-08
DE10227935A1 (de) 2004-01-15
ES2268220T3 (es) 2007-03-16
US7030093B2 (en) 2006-04-18
ZA200304798B (en) 2004-04-29
AU2003204863A1 (en) 2004-01-15
EP1374923B1 (de) 2006-08-30
ATE337802T1 (de) 2006-09-15
CN1310682C (zh) 2007-04-18
CN1480226A (zh) 2004-03-10
JP2004067679A (ja) 2004-03-04
BRPI0302074B1 (pt) 2018-02-14
JP4838488B2 (ja) 2011-12-14
DE50304820D1 (de) 2006-10-12
DE10262176B4 (de) 2007-10-04
US20040048786A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
BR0302074A (pt) Revestimento antibiótico de corpos porosos e processos para produção, bem como uso da mesma
WO2004084965A3 (en) Improved osteoinductive materials
NO20001973L (no) Fluidisert polymersuspensjon av hydrofobisk modifiset poly-
DE69938420D1 (de) Wässrige grundierungszusammensetzung oder beschichtungsmittel
BR9916438A (pt) Polimetilsilsesquioxano poroso, processo de preparação de um polimetilsilsesquioxano poroso sob forma de pó, utilização de um polimetilsilsesquioxano e composição perfumante ou perfumada
WO2006118776A3 (en) System and method for programming an inactivity timer
ATE290049T1 (de) Membran oder matrix zur steuerung der freisetzungsgeschwindigkeit von arzneistoffen
CY1108043T1 (el) Πορωδη σωματα με αντιβιοτικη επικαλυψη, μεθοδος παραγωγης και χρηση
ES2172217T3 (es) Suspensiones de furoato de mometasona para nebulizacion.
BR9917305A (pt) Meio de recepção de tinta, conjunto de tinta/meio de recepção de tinta, e, processo de produção de um meio de recepção de tinta
EP4095188A4 (en) POLYANILINE COMPOSITION, COATING FILM, POLYANILINE CONTAINING POROUS BODY AND METHOD FOR PRODUCING A COATING FILM OR POLYANILINE CONTAINING POROUS BODY
BR0301708A (pt) Preparação farmacêutica com liberação de substância ativas retardada, processo para produção e uso da mesma
DE60229031D1 (de) Verfahren zur Steuerung des Betriebs eines Systems, Untersystems oder eines Teils
NO941847L (no) Fremgangsmåte og middel til å frembringe og opprettholde et biologisk rent rommiljö
BR0304303B1 (pt) Composição para um sistema espessante hidrofóbico de viscosidade reduzida para o espessamento de um sistema aquoso contendo polímero, e, métodos para fornecer um sistema espessante de viscosidade reduzida para um sistema aquoso contendo polímero e para aumentar a viscosidade de um sistema aquoso contendo polímero
DE59902595D1 (de) Wässrige, filmbildende zubereitungen auf acrylat-basis zur beschichtung mineralischer formkörper
FR2871791B1 (fr) Procede de traitement de milieux aqueux comprenant des sels metalliques de type nitrates ou sulfates
ITMO990240A0 (it) Sistema di comando desmodromico ad attuazione oleodinamica per le valv ole dei motori alternativi endotermici
BR0000469A (pt) Sistema portador, e, elemento de prisão.
Soltis INDUSTRY UPDATE.
EA200000816A1 (ru) Применение 2-амино-6-трифторметоксибензотиазола для профилактики или лечения дисфункции мозжечка
FI19991943A (fi) Kemiallinen yhdiste, joka estää mikro-organismi/vesisuspension jäätymisen, säilyttää mikro-organismit elinkelpoisina ja lisää niiden kasvua
ES1039647Y (es) Disposicion perfeccionada aplicable para el revestimiento de superficies verticales.
ES1049620Y (es) Sistema de anclaje para marcos de puertas metalicas.
ES1043521Y (es) Fresa multiple perfeccionada, aplicable para el vaciado de bloques petreos o similares.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: HERAEUS KULZER GMBH (DE)

B25A Requested transfer of rights approved

Owner name: HERAEUS MEDICAL GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2624 DE 20-04-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.